Abraaj Backs Ugandan Pharmacy Chain (Sub-Saharan Africa)

Emerging markets private equity firm The Abraaj Group has invested in Ugandan pharmacy retail chain Vine Pharmaceuticals through its US$105.4 million Africa Health Fund. Vine currently operates 21 stores, and Abraaj’s investment is intended to help Vine gain a larger share of the Ugandan market. Financial details of the… Read More

Amethis Finance Holds First Close for Africa Fund (Africa)

Africa-focused private investment fund Amethis Finance has held a first close with US$140 million in equity commitments. Shareholders in the fund include the Edmond de Rothschild group, other banks and financial institutions, corporates and family offices from the United States, Europe and the Mediterranean. Additionally, the Overseas Private Investment… Read More

Ethos Fund VI Raises US$800 Million (Sub-Saharan Africa)

South African fund manager Ethos Private Equity has closed its sixth private equity fund, Ethos Fund VI, with US$800 million in capital commitments. Institutional investors participating in the fund included corporate pension funds, sovereign wealth funds and funds of funds. Ethos Fund VI will focus primarily on South Africa… Read More

Fanisi Backs Sophar (Sub-Saharan Africa)

East Africa-focused private equity firm Fanisi Venture Capital Management has invested in Rwandan pharmaceutical company Sophar. The funding will allow Sophar to build a World Health Organization-certified warehouse, which will increase the company’s storage capacity from 900 products to 3,000 products. Financial details of the transaction were not disclosed. Read More

Catalyst Buys Chai Bora from TransCentury (Sub-Saharan Africa)

East Africa-focused private equity firm Catalyst Principal Partners has acquired a 95 percent stake in Tanzanian packaged tea producer Chai Bora from Kenya-based investment holding company TransCentury. Catalyst invested in the company through Catalyst Fund I, its US$125 million focused private equity fund. Financial details of the transaction were… Read More

Taking Stock of 2012 and the Prospects for EM PE in 2013

As 2012 came to a close, EMPEA reached out to a number of the industry’s leading practitioners to solicit their reflections on the year gone by, and to glean insights on the prospects for emerging markets private equity in the year ahead. The Global Firms’ Views Paul Fletcher, Senior Partner,… Read More

(default archive template)